Clinical variables | CRRT discontinuation group (n = 517) | HD initiation group (n = 310) | CRRT re-initiation group (n = 349) | p value |
---|---|---|---|---|
Age (years) | 62.1 (15.2) | 61.0 (14.9) | 61.9 (14.8) | 0.613 |
Male | 330 (63.8%) | 197 (63.5%) | 222 (63.6%) | 0.996 |
Comorbidity | ||||
 Hypertension | 185 (35.8%) | 142 (45.8%) | 95 (27.2%) | < 0.001cde |
 Diabetes mellitus | 136 (26.3%) | 94 (30.3%) | 81 (23.2%) | 0.118 |
 Ischemic heart disease | 36 (7.0%) | 17 (5.5%) | 17 (4.9%) | 0.408 |
 Liver cirrhosis | 31 (6.0%) | 24 (7.7%) | 34 (9.7%) | 0.123 |
 Heart failure | 22 (4.3%) | 19 (6.1%) | 15 (4.3%) | 0.420 |
At CRRT initiation | ||||
 BUN (mmol/L) | 30.0 (12.1) | 21.8 (10.8) | 19.9 (10.8) | 0.106 |
 Serum creatinine (μmol/L) | 228.1 (145.0–351.8) | 353.6 (223.7–548.1) | 225.4 (147.6–337.7) | < 0.001ac |
 Urine output (mL/day) | 570 (180–1308) | 116 (0–361) | 244 (32–835) | < 0.001abc |
Day −1 before CRRT discontinuation | ||||
 BUN (mmol/L) | 13.4 (9.1) | 13.6 (7.9) | 13.4 (7.75) | 0.924 |
 Serum creatinine (μmol/L) | 134.4 (91.9–209.5) | 191.8 (122.9–302.3) | 143.2 (99.0–224.5) | < 0.001ac |
 Urine output (mL/day) | 565 (252–1250) | 45 (5–190) | 60 (10–289) | < 0.001ab |
 Mean blood pressure (mmHg) | 79.4 (15.1) | 78.5 (15.4) | 79.6 (15.0) | 0.631 |
 Vasopressor use | 342 (66.2%) | 202 (65.2%) | 241 (69.1%) | 0.530 |
Duration of CRRT (days) | 3.4 (2.6) | 4.8 (5.1) | 4.8 (5.0) | < 0.001ab |
Use of diuretics after CRRT | 388 (75.0%) | 129 (41.6%) | 102 (29.2%) | < 0.001abc |